Entering text into the input field will update the search result below

Rocket stock rises amid data from multiple gene therapy programs

May 19, 2023 7:20 AM ETRocket Pharmaceuticals, Inc. (RCKT) StockBy: Ravikash Bakolia, SA News Editor
DNA molecule

Artur Plawgo

Rocket Pharmaceuticals (NASDAQ:RCKT) reported data from several gene therapy programs at the 26th Annual Meeting of the American Society of Gene and Cell Therapy in Los Angeles.

Pyruvate Kinase Deficiency (PKD)

The company reported data from two two adult patients followed

Recommended For You

More Trending News

About RCKT Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
RCKT--
Rocket Pharmaceuticals, Inc.